About

Ramez Philips is a head and neck surgical oncologist whose research focuses on optimizing treatment strategies for oropharyngeal and oral cavity squamous cell carcinoma, with a particular emphasis on transoral robotic surgery (TORS) outcomes. His work addresses critical gaps in head and neck oncology, especially the lack of high-powered randomized trials comparing surgical and non-surgical approaches. Philips has made significant contributions by demonstrating that elderly patients can achieve favorable functional and survival outcomes after TORS, challenging assumptions about age-based treatment limitations. His investigation into preoperative immune checkpoint inhibition for head and neck cancer, cited 13 times, provides early evidence on safety profiles in this emerging treatment paradigm. With over 60 total citations, his most influential 2023 study comparing primary surgery versus chemoradiation for T1-T2 oropharyngeal cancer (24 citations) helps guide clinical decision-making in this controversial area. Philips has also identified risk factors for gastrostomy tube dependence and analyzed national trends in positive margin rates, informing surgical quality improvement. His work consistently bridges the gap between surgical innovation and evidence-based practice in head and neck oncology.

Research Focus

Key Achievements

4
H-Index
6
Papers
63
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma
24 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Thomas Jefferson University Hospital, Thomas Jefferson University, Jefferson University Hospitals, Vanderbilt University Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago